Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Mar 19;22(5):89.
doi: 10.3892/br.2025.1967. eCollection 2025 May.

Investigation into the casual or causal association of cerebral venous thrombosis and myelin oligodendrocyte glycoprotein antibody‑associated disease: A case report and literature review

Affiliations
Case Reports

Investigation into the casual or causal association of cerebral venous thrombosis and myelin oligodendrocyte glycoprotein antibody‑associated disease: A case report and literature review

Oreste Marsico et al. Biomed Rep. .

Abstract

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a central nervous system demyelinating syndrome (DS) typically presenting with optic neuritis or myelitis. The association between cerebral venous thrombosis (CVT) and demyelinating diseases, including multiple sclerosis (MS), is rare. In the present study, a 37-year-old man presented with sensory disturbances in the lower limbs and urinary incontinence, consistent with myelitis. The diagnosis of MOGAD was confirmed by spinal magnetic resonance imaging findings and serum anti-MOG antibody positivity using a cell-based assay. The patient responded successfully to intravenous corticosteroid therapy. However, shortly after recovery, the patient developed a persistent headache and suffered an epileptic seizure, which was later attributed to CVT. The patient was treated with low molecular weight heparin and lacosamide and subsequently returned to baseline health status without seizure recurrence in the following year. Comprehensive review of the literature on CVT associated with DS, encompassing 15 case reports, two case series and two studies, underscores the rarity of this condition. Most reported cases of CVT have been linked to MS, while only three cases of CVT associated with MOGAD have been documented to date. Additional risk factors, such as lumbar puncture and high-dose corticosteroid treatment, have been implicated in some instances. Given their shared inflammatory basis, a thrombotic-inflammatory pathogenic mechanism acting between DS and CVT in predisposed individuals is plausible. However, the exact pathogenic association between these conditions remains largely unclear, and a coincidental association cannot be ruled out. The role of anti-MOG antibodies in this rare condition also warrants further investigation.

Keywords: MOGAD; MS; cerebral sinus thrombosis; demyelinating disorders.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Spine magnetic resonance imaging. Hyperintense cervical cord lesions (arrows) in short-TI inversion recovery sagittal sequences.
Figure 2
Figure 2
Brain MRI and MR venography findings. MRI (A) axial and (B) coronal sequences showing right parietal fluid-attenuated inversion recovery hyperintensity involving postcentral and precentral gyri (arrowhead). MR venography displaying superior sagittal sinus stenosis (arrows) in (C) axial and (D) coronal views. MR, magnetic resonance; MRI, MR imaging.

References

    1. Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, Ramanathan S, Waters P, Tenembaum S, Graves JS, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol. 2023;22:268–282. doi: 10.1016/S1474-4422(22)00431-8. - DOI - PubMed
    1. Al-Ani A, Chen JJ, Costello F. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): Current understanding and challenges. J Neurol. 2023;270:4132–4150. doi: 10.1007/s00415-023-11737-8. - DOI - PMC - PubMed
    1. Häußler V, Trebst C, Engels D, Pellkofer H, Havla J, Duchow A, Schindler P, Schwake C, Pakeerathan T, Fischer K, et al. Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD. J Neurol Neurosurg Psychiatry: jnnp-2024-334764, 2024. - PubMed
    1. Silvis SM, de Sousa DA, Ferro JM, Coutinho JM. Cerebral venous thrombosis. Nat Rev Neurol. 2017;13:555–565. doi: 10.1038/nrneurol.2017.104. - DOI - PubMed
    1. Koudriavtseva T, Renna R, Plantone D, Mainero C. Demyelinating and thrombotic diseases of the central nervous system: Common pathogenic and triggering factors. Front Neurol. 2015;6(63) doi: 10.3389/fneur.2015.00063. - DOI - PMC - PubMed

Publication types

LinkOut - more resources